AS
Alec Stranahan BofA Securities Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
9
Avg Return
Past Year
Past Year
134%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
44.4%
Neutral
33.3%
Negative
22.2%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $318 |
23%
upside
| 3 | +23% |
0
%
| 22 Jan ‘26 1 month ago |
|
|
|
Neutral
Downgraded
| $7 |
36%
upside
| 1 | -25% |
–
| 3 Sep ‘25 6 months ago |
|
|
|
Neutral
Downgraded
| $12 |
1%
upside
| 1 | – |
–
| 3 Sep ‘25 6 months ago |
|
|
|
Underperform
Downgraded
| $1 |
94%
downside
| 1 | -885% |
0
%
| 3 Sep ‘25 6 months ago |
|
|
|
Underperform
Downgraded
| $7 |
34%
downside
| 2 | -11% |
0
%
| 20 Aug ‘25 6 months ago |
|
|
|
Buy
Upgraded
| $42 |
52%
upside
| 1 | +24% |
0
%
| 28 Mar ‘25 11 months ago |
|